Board Meeting Details

The Board of Directors meeting was held on July 27, 2026, commencing at 4:30 PM and concluding at 5:35 PM. The Board considered and approved:

  • Un-audited Standalone Financial Results for the quarter ended June 30, 2026
  • Un-audited Consolidated Financial Results for the quarter ended June 30, 2026
  • Taken note of Limited Review Reports issued by Statutory Auditors on both standalone and consolidated financial results

Standalone Financial Results (₹ lakhs)

Quarter ended June 30, 2026:

  • Revenue from operations: 42,273.75 (vs 31,937.88 in Q1 FY2026)
  • Other Income: 616.79
  • Total Income: 42,890.54
  • Profit before tax: 9,781.80 (vs 5,234.02 in Q1 FY2026)
  • Tax expense: 2,567.56 (Current tax: 2,022.60, Deferred tax: 496.45, Earlier years' tax: 48.51)
  • Profit for the period: 7,214.24 (vs 3,979.96 in Q1 FY2026)
  • Total comprehensive income: 7,214.24
  • Earnings per share (Basic & Diluted): ₹22.27 (vs ₹12.28 in Q1 FY2026)
  • Paid-up equity share capital: 648.02 (Face Value ₹2 per share)
  • Other equity: 1,77,848.62

Consolidated Financial Results (₹ lakhs)

Quarter ended June 30, 2026:

  • Revenue from operations: 45,592.56 (vs 35,834.12 in Q1 FY2026)
  • Other Income: 552.49
  • Total Income: 46,145.05
  • Profit before tax: 10,620.36 (vs 4,901.34 in Q1 FY2026)
  • Tax expense: 2,808.59 (Current tax: 2,256.42, Deferred tax: 503.66, Earlier years' tax: 48.51)
  • Profit for the period: 7,811.77 (vs 3,652.72 in Q1 FY2026)
  • Attributable to Owners of the Parent: 7,493.66
  • Attributable to Non-controlling interests: 318.11
  • Total comprehensive income: 7,811.77
  • Attributable to Owners of the Parent: 7,493.66
  • Attributable to Non-controlling interests: 318.11
  • Earnings per share (Basic & Diluted): ₹23.13 (vs ₹11.73 in Q1 FY2026)
  • Paid-up equity share capital: 648.02 (Face Value ₹2 per share)
  • Other equity: 1,96,997.59

Segment Reporting (Consolidated, ₹ lakhs)

Quarter ended June 30, 2026:

  • Amines & Speciality Chemicals:
  • Revenue: 45,288.92
  • Segment Results before Tax & Interest: 10,544.76
  • Interest: 135.38
  • Segment Profit before tax: 10,409.38
  • Segment Assets: 2,57,731.41
  • Segment Liabilities: 28,958.53
  • Hotel Division:
  • Revenue: 798.81
  • Segment Results before Tax & Interest: 159.78
  • Interest: 5.84
  • Segment Profit before tax: 153.93
  • Segment Assets: 6,315.10
  • Segment Liabilities: 1,316.39
  • Unallocated:
  • Revenue: 124.50
  • Segment Results before Tax & Interest: 57.04
  • Interest: 0.00
  • Segment Profit before tax: 57.04
  • Segment Assets: 2,676.28
  • Segment Liabilities: 13,467.89

Notes to Financial Results

1. The unaudited results were reviewed by the Audit Committee and approved by the Board of Directors on July 27, 2026. Statutory Auditors expressed an unmodified opinion.

2. Financial results prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under section 133 of the Companies Act, 2013.

3. Consolidated financial results prepared based on Ind AS 110 and include results of subsidiary, Balaji Speciality Chemicals Limited.

4. Segment information given as per Ind AS-108 'Operating Segments'.

5. Statement prepared as per Regulation 33 of SEBI (LODR) Regulations, 2015.

Auditor's Review Reports

M. Anandam & Co., Chartered Accountants issued unmodified review reports on both standalone and consolidated financial results, stating that nothing has come to their attention that causes them to believe the statements contain any material misstatement. The reviews were conducted in accordance with SRE 2410 issued by ICAI.